Package 70518-2293-0

{"route": ["ORAL"], "spl_id": "49f0fba1-e922-aee8-e063-6394a90a8d75", "openfda": {"unii": ["4182431BJH"], "rxcui": ["855671"], "spl_set_id": ["844a16db-17d5-44da-819d-54f3e19cfec2"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (70518-2293-0)", "package_ndc": "70518-2293-0", "marketing_start_date": "20190903"}, {"sample": false, "description": "100 POUCH in 1 BOX (70518-2293-1)  / 1 CAPSULE, EXTENDED RELEASE in 1 POUCH (70518-2293-2)", "package_ndc": "70518-2293-1", "marketing_start_date": "20210805"}], "brand_name": "Phenytoin Sodium", "product_id": "70518-2293_49f0fba1-e922-aee8-e063-6394a90a8d75", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "70518-2293", "generic_name": "Phenytoin Sodium", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phenytoin Sodium", "active_ingredients": [{"name": "PHENYTOIN SODIUM", "strength": "100 mg/1"}], "application_number": "ANDA040684", "marketing_category": "ANDA", "marketing_start_date": "20190903", "listing_expiration_date": "20271231"}